Published in J Exp Med on October 01, 1980
Monoclonal antibodies to nucleic acid-containing cellular constituents: probes for molecular biology and autoimmune disease. Proc Natl Acad Sci U S A (1981) 10.72
Antigen presentation by Ia+ B cell hybridomas to H-2-restricted T cell hybridomas. Proc Natl Acad Sci U S A (1982) 3.41
Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc Natl Acad Sci U S A (1983) 2.57
Inhibition of antigen-specific T lymphocyte activation by structurally related Ir gene-controlled polymers. Evidence of specific competition for accessory cell antigen presentation. J Exp Med (1983) 1.92
Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH. J Exp Med (1991) 1.92
Mechanisms influencing the immunodominance of T cell determinants. J Exp Med (1988) 1.91
HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med (1996) 1.66
Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition. J Exp Med (1985) 1.46
Selective loss of antigen-specific Ir gene function in IA mutant B6.C-H-2bm12 is an antigen presenting cell defect. Proc Natl Acad Sci U S A (1981) 1.40
Reconstitution of Ir genes, Ia antigens, and mixed lymphocyte reaction determinants by gene complementation. Proc Natl Acad Sci U S A (1981) 1.35
T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen. J Exp Med (1993) 1.31
T cell clones reactive with sperm whale myoglobin. Isolation of clones with specificity for individual determinants on myoglobin. J Exp Med (1981) 1.23
The beta 1 domain of the mouse E beta chain is important for restricted antigen presentation to helper T-cell hybridomas. Proc Natl Acad Sci U S A (1985) 1.21
Conversion of immunity to suppression by in vivo administration of I-A subregion-specific antibodies. J Exp Med (1982) 1.19
Multiple functional sites on a single Ia molecule defined using T cell clones and antibodies with chain-determined specificity. J Exp Med (1984) 1.18
Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients. J Exp Med (1986) 1.18
Reactivity of V beta 17a+ CD8+ T cell hybrids. Analysis using a new CD8+ T cell fusion partner. J Exp Med (1989) 1.17
Antigen-specific T cell clones restricted to unique F1 major histocompatibility complex determinants. Inhibition of proliferation with monoclonal anti-Ia antibody. J Exp Med (1981) 1.16
Use of somatic cell genetics to study chromosomes contributing to antigen plus I recognition by T cell hybridomas. J Exp Med (1983) 1.14
Subpopulations of B cells distinguished by cell surface expression of Ia antigens. Correlation of Ia and idiotype during activation by cloned Ia-restricted T cells. J Exp Med (1983) 1.13
Identification of a new component in the murine Ia molecular complex. J Exp Med (1983) 1.09
A novel type of T-T cell interaction removes the requirement for I-B region in the H-2 complex. Proc Natl Acad Sci U S A (1981) 1.08
Mechanism responsible for the induction of I-J restriction on TS3 suppressor cells. J Exp Med (1982) 1.07
Actin-binding protein 1 regulates B cell receptor-mediated antigen processing and presentation in response to B cell receptor activation. J Immunol (2008) 1.05
Functional and inducible expression of a transfected murine class II major histocompatibility complex gene. Proc Natl Acad Sci U S A (1984) 1.05
Gene for a major cell surface glycoprotein of mouse macrophages and other phagocytic cells is on chromosome 2. Proc Natl Acad Sci U S A (1982) 1.05
The xid gene controls Ia.W39-associated immune response gene function. J Exp Med (1981) 1.04
HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J Clin Invest (1997) 1.01
T cell surface I-J glycoprotein. Concerted action of chromosome-4 and -17 genes forms an epitope dependent on alpha-D-mannosyl residues. J Exp Med (1984) 1.01
Expression of an idiotype (Id-460) during in vivo anti-dinitrophenyl antibody responses. III. Detection of Id-460 in normal serum that does not bind dinitrophenyl. J Exp Med (1981) 0.99
Mixed isotype class II antigen expression. A novel class II molecule is expressed on a murine B cell lymphoma. J Exp Med (1989) 0.96
Role of the H-2 complex in induction of T helper cells in vivo. II Negative selection of discrete subgroups of T cells restricted by I-A and I-A/E determinants. J Exp Med (1981) 0.96
How to make a hybridoma. Yale J Biol Med (1982) 0.94
Antigen presentation by murine and human cells to a murine T-cell hybridoma: demonstration of a restriction element associated with a major histocompatibility complex class II determinant(s) shared by both species. Proc Natl Acad Sci U S A (1984) 0.94
Prevention of systemic lupus erythematosus in autoimmune BXSB mice by a transgene encoding I-E alpha chain. J Exp Med (1993) 0.92
Arsonate-specific murine T cell clones. I. Genetic control and antigen specificity. J Exp Med (1983) 0.90
Evidence for two suppressor factors secreted by a single cell suggests a solution to the J-locus paradox. Proc Natl Acad Sci U S A (1983) 0.90
Inhibition of T cell activation in vivo with mixtures of monoclonal antibodies specific for I-A and I-A/E molecules. J Exp Med (1981) 0.90
Evidence for a functional interaction between the beta chain of major histocompatibility complex class II and the T cell receptor alpha chain during recognition of a bacterial superantigen. J Exp Med (1994) 0.89
Analysis of H-2 determinants recognized during the induction of H-Y-immune cytotoxic T cells by monoclonal antibodies in vitro. J Exp Med (1981) 0.89
Quantitative analysis of integrated Ed alpha gene expression in C57BL/6 transgenic mice. Immunology (1988) 0.88
Aberrant Ae (E beta) Ia polypeptide chain in H-2g2 haplotype mice. Possible result of an intragenic recombination or mutation. J Exp Med (1980) 0.87
Predicted protein sequence of the murine I-E-beta S-polypeptide chain from cDNA and genomic clones. Proc Natl Acad Sci U S A (1985) 0.85
Monoclonal suppressor factor specific for lactate dehydrogenase B. I. Mechanism of interaction between the factor and its target cells. J Exp Med (1983) 0.84
Clonal analysis of F1 hybrid helper T cells. I-A subregion-encoded hybrid determinants restrict the activity of keyhole limpet hemocyanin-specific helper T cells. J Exp Med (1981) 0.84
A novel H2A-E+ transgenic model susceptible to human but not mouse thyroglobulin-induced autoimmune thyroiditis: identification of mouse pathogenic epitopes. Cell Immunol (2008) 0.83
Restriction molecules involved in the interaction of T cells with allogeneic antigen-presenting cells. J Exp Med (1982) 0.82
Exogenously provided peptides of a self-antigen can be processed into forms that are recognized by self-T cells. J Exp Med (1998) 0.82
Cutting edge: NADPH oxidase modulates MHC class II antigen presentation by B cells. J Immunol (2012) 0.81
H2E-derived Ealpha52-68 peptide presented by H2Ab interferes with clonal deletion of autoreactive T cells in autoimmune thyroiditis. J Immunol (2008) 0.81
CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition. Immunology (1989) 0.80
Existence of mixed isotype A beta E alpha class II molecules in Ed alpha gene-introduced C57BL/6 transgenic mice. Immunology (1990) 0.80
Inhibition by Fab and Fab'2 monoclonal anti-Ia antibody fragments of T-lymphocyte proliferative responses. Immunology (1982) 0.80
Antigen-reactive T cell clones restricted by mixed isotype A beta d/E alpha d class II molecules. J Exp Med (1990) 0.79
Role of Ia antigens in graft vs. host reactions. II. Molecular and functional analysis of T cell alloreactivity by the characterization of host Ia antigens on alloactivated donor T cells. J Exp Med (1982) 0.78
'Autoreactivity' of some hybridomas may be caused by a three-cell interaction. Immunology (1988) 0.77
Murine T cell-specific Ia antigens: monoclonal antibodies define an I-A-encoded T lymphocyte structure. Proc Natl Acad Sci U S A (1982) 0.76
Anti-I-A antibody modulation of lymphocyte traffic in hapten-stimulated inbred mice. Immunology (1987) 0.75
Role of the H-2 complex in induction of T helper cells in vivo. III. Contribution of the I-E subregion to restriction sites recognized by I-A/E-restricted T cells. J Exp Med (1982) 0.75
B lymphocyte immune response gene phenotype is genetically determined. J Exp Med (1982) 0.75
High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell (1977) 30.04
SELECTION OF HYBRIDS FROM MATINGS OF FIBROBLASTS IN VITRO AND THEIR PRESUMED RECOMBINANTS. Science (1964) 24.40
Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry (1978) 22.56
A better cell line for making hybridomas secreting specific antibodies. Nature (1978) 15.13
X-ray intensifying screens greatly enhance the detection by autoradiography of the radioactive isotopes 32P and 125I. Anal Biochem (1978) 10.28
Immune responses in vitro. I. Culture conditions for antibody synthesis. Cell Immunol (1972) 6.04
Two-gene control of the expression of a murine Ia antigen. J Exp Med (1978) 4.79
Macrophage Ia antigens. I. macrophage populations differ in their expression of Ia antigens. J Immunol (1978) 4.04
The immune response genes of the major histocompatibility complex. Immunol Rev (1978) 3.61
Mitochondrial cytochrome c: preparation and activity of native and chemically modified cytochromes c. Methods Enzymol (1978) 2.87
T lymphocyte-enriched murine peritoneal exudate cells. III. Inhibition of antigen-induced T lymphocyte Proliferation with anti-Ia antisera. J Immunol (1976) 2.64
B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse. J Exp Med (1979) 2.28
T-lymphocyte-enriched murine peritoneal exudate cells. II. Genetic control of antigen-induced T-lymphocyte proliferation. J Exp Med (1976) 2.27
Organization of the immune response genes. Science (1979) 2.18
Antigenic requirements for triggering of cytotoxic T lymphocytes. Immunol Rev (1977) 1.82
Cellular cooperation during in vivo anti-hapten antibody responses. I. The effect of cell number on the response. J Immunol (1975) 1.81
Cross-reactivity between H-2K and H-2D products. I. Evidence for extensive and reciprocal serological cross-reactivity. J Exp Med (1975) 1.58
Inhibition of dual Ir gene-controlled T-lymphocyte proliferative response to poly (Glu56Lys35Phe9)n with anti-Ia antisera directed against products of either I-A or I-C subregion. Proc Natl Acad Sci U S A (1978) 1.55
Gene complementation. Neither Ir-GLphi gene need be present in the proliferative T cell to generate an immune response to Poly(Glu55Lys36Phe9)n. J Exp Med (1980) 1.49
Inhibition of stimulation in murine mixed lymphocyte cultures with an alloantiserum directed against a shared Ia determinant. J Immunol (1976) 1.46
Crossreactive mixed lymphocyte reaction determinants recognized by cloned alloreactive T cells. Proc Natl Acad Sci U S A (1979) 1.39
The Fc receptor on thymus-derived lymphocytes. IV. Inhibition of binding of antigen-antibody complexes to Fc receptor-positive T cells by anti-Ia sera. J Exp Med (1977) 1.39
Serological and biochemical identification of hybrid Ia antigens. J Exp Med (1980) 1.38
An antigen-specific I region gene product that augments the antibody response. J Immunol (1978) 1.28
T-cell-specific murine Ia antigens: serology of I-J and I-E subregion specificities. J Exp Med (1978) 1.12
Nature of the T-cell receptor. Both the T-cell receptor and antigen-specific T-cell-derived factors are coded for by V genes but express anti-self idiotypes indirectly determined by major histocompatibility complex genes. Scand J Immunol (1979) 1.07
The distribution of Ia antigens on the surfaces of lymphocytes. J Immunol (1976) 1.00
Rapid binding test for detection of alloantibodies to lymphocyte surface antigens. Curr Top Microbiol Immunol (1978) 0.93
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature (1997) 23.92
Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. Curr Top Microbiol Immunol (1978) 13.40
Monoclonal antibodies to nucleic acid-containing cellular constituents: probes for molecular biology and autoimmune disease. Proc Natl Acad Sci U S A (1981) 10.72
CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XII. THE USE OF CONCENTRATED NORMAL HUMAN SERUM GAMMA GLOBULIN (HUMAN IMMUNE SERUM GLOBULIN) IN THE PREVENTION AND ATTENUATION OF MEASLES. J Clin Invest (1944) 10.24
Innate immunity: the virtues of a nonclonal system of recognition. Cell (1997) 9.42
Phylogenetic perspectives in innate immunity. Science (1999) 9.42
MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell (1998) 8.73
STUDIES ON THE PLASMA PROTEINS. V. THE EFFECT OF CONCENTRATED SOLUTIONS OF HUMAN AND BOVINE SERUM ALBUMIN ON BLOOD VOLUME AFTER ACUTE BLOOD LOSS IN MAN. J Clin Invest (1943) 8.26
Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol (1989) 7.69
T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu Rev Immunol (1985) 6.98
G protein signaling events are activated at the leading edge of chemotactic cells. Cell (1998) 6.60
Association of high-molecular-weight proteins with microtubules and their role in microtubule assembly in vitro. Proc Natl Acad Sci U S A (1975) 6.35
A new I subregion (I-J) marked by a locus (Ia-4) controlling surface determinants on suppressor T lymphocytes. J Exp Med (1976) 6.11
Sequence analysis of peptides bound to MHC class II molecules. Nature (1991) 5.99
Innate immunity: impact on the adaptive immune response. Curr Opin Immunol (1997) 5.62
Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J Immunol (1984) 5.51
Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med (1987) 5.48
Purification of tubulin and associated high molecular weight proteins from porcine brain and characterization of microtubule assembly in vitro. Ann N Y Acad Sci (1975) 5.26
HISTOLOGICAL AND SEROLOGICAL SEQUENCES IN EXPERIMENTAL HYPERSENSITIVITY. J Exp Med (1947) 5.11
Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med (1993) 4.99
Microtubules: evidence for 13 protofilaments. J Cell Biol (1973) 4.91
Two-gene control of the expression of a murine Ia antigen. J Exp Med (1978) 4.79
Activation of gamma delta T cells in the primary immune response to Mycobacterium tuberculosis. Science (1989) 4.19
Medicinal applications of delta-9-tetrahydrocannabinol and marijuana. Ann Intern Med (1997) 4.08
A novel population of T-cell receptor alpha beta-bearing thymocytes which predominantly expresses a single V beta gene family. Nature (1987) 3.96
Specificity and function of T cells bearing gamma delta receptors. Immunol Today (1988) 3.93
A subset of CD4+ thymocytes selected by MHC class I molecules. Science (1994) 3.87
Correlations between T-cell specificity and the structure of the antigen receptor. Nature (1986) 3.83
Interaction between antigen-presenting cells and primed T lymphocytes: an assessment of Ir gene expression in the antigen-presenting cell. Immunol Rev (1978) 3.67
Monoclonal antibodies against the antigen receptor on a cloned T-cell hybrid. Proc Natl Acad Sci U S A (1983) 3.66
Nomenclature for the major histocompatibility complexes of different species: a proposal. Immunogenetics (1990) 3.53
Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J Exp Med (1990) 3.45
Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat Med (1999) 3.45
Activation events during thymic selection. J Exp Med (1992) 3.43
On the complexity of self. Nature (1991) 3.43
The fine specificity of antigen and Ia determinant recognition by T cell hybridoma clones specific for pigeon cytochrome c. Cell (1982) 3.38
Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med (1996) 3.36
Two different VH gene products make up the T-cell receptors. Scand J Immunol (1976) 3.32
Analysis of H-2 and Ia molecules by two-dimensional gel electrophoresis. J Exp Med (1977) 3.26
Leishmaniasis. J Am Acad Dermatol (1996) 3.14
The gamma globulins. 3. The antibody deficiency syndromes. N Engl J Med (1966) 3.03
Selective expression of H-2 (i-region) loci controlling determinants on helper and suppressor T lymphocytes. J Exp Med (1976) 2.94
Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition. Immunity (1999) 2.89
Intestinal intraepithelial lymphocytes are a distinct set of gamma delta T cells. Nature (1988) 2.89
Detection of a common polypeptide chain in I--A and I--E sub-region immunoprecipitates. Mol Immunol (1979) 2.86
Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. J Immunol (1987) 2.85
Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted. Nature (1981) 2.85
Deletion of self-reactive thymocytes occurs at a CD4+8+ precursor stage. Nature (1988) 2.84
Contrasuppression. A novel immunoregulatory activity. J Exp Med (1981) 2.84
Dynamic distribution of chemoattractant receptors in living cells during chemotaxis and persistent stimulation. J Cell Biol (1997) 2.78
Evidence for an immunoglobulin-dependent antigen-specific helper T cell. Proc Natl Acad Sci U S A (1977) 2.72
Antigen presentation by resting B cells. Radiosensitivity of the antigen-presentation function and two distinct pathways of T cell activation. J Exp Med (1984) 2.71
In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B. J Exp Med (1990) 2.69
T lymphocyte-enriched murine peritoneal exudate cells. III. Inhibition of antigen-induced T lymphocyte Proliferation with anti-Ia antisera. J Immunol (1976) 2.64
Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med (1991) 2.60
Contribution of antigen-presenting cell major histocompatibility complex gene products to the specificity of antigen-induced T cell activation. J Exp Med (1982) 2.58
Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc Natl Acad Sci U S A (1987) 2.57
Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc Natl Acad Sci U S A (1983) 2.57
The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J Immunol (1987) 2.55
Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.54
Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen-presenting cells. J Immunol (1988) 2.48
A rapid sensitive assay for specific protein synthesis in cells and in cell-free translations: use of Staphylococcus aureus as an adsorbent for immune complexes. Anal Biochem (1979) 2.48
TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell (1993) 2.43
Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J Exp Med (1992) 2.42
CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med (1996) 2.42
Receptor-directed focusing of lymphokine release by helper T cells. Nature (1988) 2.41
Implantation of a foetal thymus, restoring immunological competence in a patient with thymic aplasia (Digeorge's syndrome). Lancet (1968) 2.40
Characterization of T cell receptor gamma chain expression in a subset of murine thymocytes. Science (1986) 2.40
Limb blood flow and vascular conductance are reduced with age in healthy humans: relation to elevations in sympathetic nerve activity and declines in oxygen demand. Circulation (1999) 2.40
Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int Immunol (1992) 2.39
Expression of MHC antigens by mouse thymic dendritic cells. J Immunol (1979) 2.39
Role of tubulin-associated proteins in microtubule nucleation and elongation. J Mol Biol (1977) 2.38
Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J Immunol (1990) 2.37
Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science (1996) 2.36
Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells. J Immunol (1984) 2.35
A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines. Eur J Immunol (1989) 2.33
Recognition of the product of a novel MHC TL region gene (27b) by a mouse gamma delta T cell receptor. Cell (1990) 2.33
Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation (1984) 2.33
Induction of Ia and H-2 antigens on a macrophage cell line by immune interferon. J Immunol (1983) 2.32
Validity of adolescent self-report of alcohol and other drug involvement. Int J Addict (1992) 2.32
Do B cells drive the diversification of immune responses? Immunol Today (1993) 2.31
Selection of amino acid sequences in the beta chain of the T cell antigen receptor. Science (1988) 2.30
The role of Fas in autoimmune diabetes. Cell (1997) 2.30
Antigen presentation in the murine T-lymphocyte proliferative response. I. Requirement for genetic identity at the major histocompatibility complex. J Exp Med (1977) 2.30
T-lymphocyte-enriched murine peritoneal exudate cells. II. Genetic control of antigen-induced T-lymphocyte proliferation. J Exp Med (1976) 2.27
Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. J Immunol (1999) 2.26
Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science (1992) 2.25